Ketamine on Acute Pain in Females and Males | NCT00232492 | Trialant

Ketamine on Acute Pain in Females and Males | NCT00232492 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Placebo males	Placebo Comparator	Saline physiological placebo males	Drug: Placebo males
Ketamine 0,1 mg/kg males	Active Comparator	0,1 mg/kg ketamine males	Drug: Ketamine 0,1 mg/kg males
Ketamine 0,3 mg/kg males	Active Comparator	0,3 mg/kg ketamine males	Drug: Ketamine 0,3 mg/kg males
Ketamine 0,5 mg/kg males	Active Comparator	0,5 mg/kg ketamine males	Drug: Ketamine 0,5 mg/kg males
Placebo females	Placebo Comparator	Saline physiological as placebo females	Drug: Placebo females
Ketamine 0.1 mg/kg females	Active Comparator	0,1 mg/kg ketamine females

Outcomes Module

Contacts/Locations Module

Overall Officials

Name	Affiliation	Role
Lasse A Skoglund, DDS, PhD	Section of Dental Pharmacology and Pharmacotherapy, Faculty of Dentistry, POB 1119 Blindern, University of Oslo, N-0317 Oslo, Norway	Study Chair
Olav Hustveit, MD	Section of Dental Pharmacology and Pharmacotherapy, Faculty of Dentistry, POB 1119 Blindern, University of Oslo, N-0317 Oslo, Norway	Principal Investigator

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
8351166	Background	Oye I, Mathisen LC. The effect of CPP in neurogenic pain: inhibition of spinal or cortical NMDA receptors? Pain. 1993 Jun;53(3):358. doi: 10.1016/0304-3959(93)90234-G. No abstract available.
	Background	Øye I, Hustveit O, Maurset A, Ratti Moberg E, Paulsen O, Skoglund LA. The chiral forms of ketamine as probes for NMDA receptor functions in humans. In: NMDA receptor related agents: Biochemistry, pharmacology and behaviour. Kameyama T, Domino E (eds). NPP Books, Ann Arbor, 1991.